Tags

Type your tag names separated by a space and hit enter

COVID-19 coagulopathy vs disseminated intravascular coagulation.
Blood Adv. 2020 06 23; 4(12):2850.BA

Authors+Show Affiliations

Department of Medicine, University College London Hospitals (UCLH) NHS Foundation Trust, London, United Kingdom; and Cardiometabolic Programme, Biomedical Research Centre, National Institute for Health Research, UCLH/University College London, London, United Kingdom.

Pub Type(s)

Address
Journal Article

Language

eng

PubMed ID

32574369

Citation

Levi, Marcel. "COVID-19 Coagulopathy Vs Disseminated Intravascular Coagulation." Blood Advances, vol. 4, no. 12, 2020, p. 2850.
Levi M. COVID-19 coagulopathy vs disseminated intravascular coagulation. Blood Adv. 2020;4(12):2850.
Levi, M. (2020). COVID-19 coagulopathy vs disseminated intravascular coagulation. Blood Advances, 4(12), 2850. https://doi.org/10.1182/bloodadvances.2020002197
Levi M. COVID-19 Coagulopathy Vs Disseminated Intravascular Coagulation. Blood Adv. 2020 06 23;4(12):2850. PubMed PMID: 32574369.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - COVID-19 coagulopathy vs disseminated intravascular coagulation. A1 - Levi,Marcel, PY - 2020/05/01/received PY - 2020/05/19/accepted PY - 2020/6/24/entrez PY - 2020/6/24/pubmed PY - 2020/7/7/medline SP - 2850 EP - 2850 JF - Blood advances JO - Blood Adv VL - 4 IS - 12 SN - 2473-9537 UR - https://www.unboundmedicine.com/medline/citation/32574369/COVID_19_coagulopathy_vs_disseminated_intravascular_coagulation_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S2473-9529(20)31261-1 DB - PRIME DP - Unbound Medicine ER -